Gyros Protein Technologies Overview
- Founded
-
2000

- Status
-
Acquired/Merged
- Employees
-
44

- Latest Deal Type
-
M&A
- Financing Rounds
-
6
- Investments
-
1
Gyros Protein Technologies General Information
Description
Developer of automated micro-immunoassays designed for therapeutic protein development. The company's microfluidics technology increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications for assisting the scientists in academia and industry for peptide synthesis and bioanalysis.
Contact Information
Website
www.gyrosproteintechnologies.com
Formerly Known As
Gyros
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Primary Office
- Uppsala Science Park
- Dag Hammarskjölds väg 54
- 751 83 Uppsala
- Sweden
+46 000000
Gyros Protein Technologies Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Gyros Protein Technologies Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of automated micro-immunoassays designed for therapeutic protein development. The company's microfluidics tech
Discovery Tools (Healthcare)
Uppsala, Sweden
44
As of 2016
000.00
0000
0000-00-00
000000&0
Gyros Protein Technologies Competitors (2)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Eppendorf | Corporation | Hamburg, Germany | 0000 | |||
0000000000 | Corporate Backed or Acquired | Torrance, CA | 000 | 000000&0 |
Gyros Protein Technologies Patents
Gyros Protein Technologies Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-20220363713-A1 | A method for modification of peptides immobilized on a solid support by traceless reductively cleavable linker molecules | Pending | 07-Aug-2019 | 0000000000 | |
AU-2020325658-A1 | A method for modification of peptides immobilized on a solid support by traceless reductively cleavable linker molecules | Pending | 07-Aug-2019 | 0000000000 | |
CA-3143662-A1 | A method for modification of peptides immobilized on a solid support by traceless reductively cleavable linker molecules | Pending | 07-Aug-2019 | 0000000000 | |
EP-4010352-A1 | A method for modification of peptides immobilized on a solid support by traceless reductively cleavable linker molecules | Pending | 07-Aug-2019 | 0000000000 | |
AU-2019328662-A1 | Traceless reductively cleavable linker molecules for peptide purification | Pending | 27-Aug-2018 | C07K1/22 |
Gyros Protein Technologies Executive Team (14)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Mårten Bergström | Director, Quality | ||
Katherine Flagg | Vice President, Global Sales & US Operations |
Gyros Protein Technologies Signals
Gyros Protein Technologies Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Gyros Protein Technologies Acquisitions (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 00000 | 16-Mar-2016 | 000000 00 | Medical Supplies |